Genexin Supplies Cervical Cancer Diagnostic Kit to Indonesia 'KDNA'

Genexin has signed a contract with Indonesia's KDNA, which is a subsidiary of Kalbe Biopharma, an Indonesian pharmaceutical company, to supply cervical cancer and sexually transmitted disease diagnostic kits.

Gynpad will be supplied through this contract. Gynpad is a pad type product that allows simple cervical cell self-harvesting by simply wearing the product without any special manipulation but for a certain period of time.

Gynpad has been developed and produced by TCM Korea and Genexin has acquired supply rights to all of Southeast Asia incluiding Indonesia, the Philippines and Singapore. 

ยป Read more: http://www.biospectator.com/view/news_view.php?varAtcId=2857